RxDoctor Payments DataLook up a doctor →

Derek Johnson, MD

Adult Reconstructive Orthopaedic Surgery · Parker, CONPI 1295946283

Payments from drug & device makers

$525,242in general payments, 2019–2025

Across 355 payments — averaging $1479.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$293K
  • Conformis, Inc.$157K
  • Restor3d, Inc.$67K
  • Omnilife Science, Inc$5K
  • Medacta USA, Inc.$1K
  • Stryker$949
  • plus $1K from 20 others
$7,086in research payments, 2019–2025

Across 11 payments — averaging $644.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corin USA$4K
  • Medacta USA, Inc.$3K
  • Omnilife Science, Inc$350

What the payments were for

  • Royalty or licence$27,00115%
  • Consulting fees$93,74252%
  • Speaking & faculty fees$40,82623%
  • Travel & lodging$12,1397%
  • Food & beverage$7,5714%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$525,242 in reported general payments places this provider in the 90th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.

See all adult reconstructive orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$379,164
Medicare patients
589
Services billed
8,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam345$2,304
Celecoxib14$546
Amoxicillin42$109
Tramadol Hcl13$70

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →